- Home
- CLX vs ROIV Comparison
CLX vs ROIV Comparison
Compare CLX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLX | ROIV |
|---|---|---|
| Founded | 1913 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 14.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLX | ROIV |
|---|---|---|
| Price | $106.01 | $22.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $126.38 | $24.31 |
| AVG Volume (30 Days) | 2.4M | ★ 8.5M |
| Earning Date | 02-02-2026 | 02-09-2026 |
| Dividend Yield | ★ 4.67% | N/A |
| EPS Growth | ★ 121.91 | N/A |
| EPS | ★ 6.38 | N/A |
| Revenue | ★ $6,771,000,000.00 | $20,329,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.80 | $741.42 |
| P/E Ratio | $16.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $96.66 | $8.73 |
| 52 Week High | $164.22 | $23.47 |
Technical Indicators
Market Signals| Indicator | CLX | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 63.00 | 55.22 |
| Support Level | $98.75 | $21.15 |
| Resistance Level | $102.41 | $22.14 |
| Average True Range (ATR) | 2.01 | 0.61 |
| MACD | 0.95 | -0.11 |
| Stochastic Oscillator | 99.47 | 61.85 |
Price Performance
Historical ComparisonAbout CLX Clorox Company (The)
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.